The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
A clinico-pathological study of subtypes in Parkinson's disease
Open accessAbstract
We have carried out a systematic review of the case files of 242 donors with pathologically verified Parkinson's disease at the Queen Square Brain Bank for Neurological Disorders in an attempt to corroborate the data-driven subtype classification proposed by Lewis and colleagues (Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 2005; 76: 343-8). Cases were segregated into earlier disease onset (25%), tremor dominant (31%), non-tremor dominant (36%) and rapid disease progression without dementia (8%) subgroups. We found a strong association between a non-tremor dominant disease pattern and cognitive disability. The earlier disease onset group had the longest duration to death, and greatest delay to the onset of falls and cognitive decline. Patients with a tremor dominant disease pattern did not live significantly longer than non-tremor dominant patients and showed no difference in mean time to onset of falls and hallucinations. Rapid disease progression was associated with older age, early depression and early midline motor symptoms, and in 70% of the cases, tremulous onset. The non-tremor dominant subgroup had a significantly higher mean pathological grading of cortical Lewy bodies than all other groupings (P < 0.05) and more cortical amyloid-beta plaque load and cerebral amyloid angiopathy than early disease onset and tremor dominant groups (P = 0.047). An analysis of cases with pathologically defined neocortical Lewy body disease confirmed the link between bradykinetic onset, cognitive decline and Lewy body deposition in the neocortex. Although neuropathological examination failed to distinguish the other subtypes, the classification scheme was supported by an analysis of clinical data that were independent of the basic subgroup definitions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“(2008) identified three clinico-pathological groupings: (i) patients with younger onset and long duration disease, where the distribution of Lewy bodies best fits the Braak staging scheme (Braak et al., 2003); (ii) a dementia dominant syndrome, with severe neocortical Lewy body changes from the outset of clinical dise…”
BackgroundMcKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · cited 1×
“As part of an ongoing investigation the principles of the Consensus Guidelines for Pathological Diagnosis of Dementia with Lewy Bodies (McKeith et al., 1996) were applied to all Parkinson’s disease cases submitted to the QSBB in order to document the distribution and severity of Lewy body pathology.”
MethodThe relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Self-citationThe Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,246
Williams, D. R., de Silva, R., Paviour, D. C., Pittman, A., Watt, H. C., Kilford, L., Holton, J. L., Revesz, T., & Lees, A. J. (2005) · Brain · doi:10.1093/brain/awh488 · Cited by 667
Self-citationDyskinesias and motor fluctuations in Parkinson's disease
Schrag, A., & Quinn, N. (2000) · Brain · doi:10.1093/brain/123.11.2297 · Cited by 600
The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease
Paulus, W., & Jellinger, K. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 554
Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach
Lewis, S. J. G. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.033530 · Cited by 551
Dementia and survival in Parkinson disease: A 12-year population study
Buter, T. C., van den Hout, A., Matthews, F. E., Larsen, J. P., Brayne, C., & Aarsland, D. (2008) · Neurology · doi:10.1212/01.wnl.0000306632.43729.24 · Cited by 451
Young onset Parkinson's disease
Quinn, N., Critchley, P., & Marsden, C. D. (1987) · Movement Disorders · doi:10.1002/mds.870020201 · Cited by 443
Burn, D. J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.081711 · Cited by 436
The progression of pathology in longitudinally followed patients with Parkinson’s disease
Halliday, G., Hely, M., Reid, W., & Morris, J. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0344-8 · Cited by 414
The heterogeneity of Parkinson's disease: Clinical and prognostic implications
Zetusky, W. J., Jankovic, J., & Pirozzolo, F. J. (1985) · Neurology · doi:10.1212/wnl.35.4.522 · Cited by 380
A comparison of clinical and pathological features of young‐ and old‐onset Parkinson's disease
Gibb, W. R. G., & Lees, A. J. (1988) · Neurology · doi:10.1212/wnl.38.9.1402 · Cited by 369
Self-citationParkinson Study Group (1996) · Annals of Neurology · doi:10.1002/ana.410390107 · Cited by 356
Jellinger, K. A. (1999) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6360-3_1 · Cited by 347
Young‐onset Parkinson's disease revisited—clinical features, natural history, and mortality
Schrag, A., Ben‐Shlomo, Y., Brown, R., David Marsden, C., & Quinn, N. (1998) · Movement Disorders · doi:10.1002/mds.870130605 · Cited by 311
Tremor in Parkinson’s disease and serotonergic dysfunction: An 11 C-WAY 100635 PET study
Doder, M., Rabiner, E. A., Turjanski, N., Lees, A. J., & Brooks, D. J. (2003) · Neurology · doi:10.1212/01.wnl.0000031424.51127.2b · Cited by 302
Self-citationNonmotor symptoms as presenting complaints in Parkinson’s disease: a clinicopathological study
O'Sullivan, S. S., Williams, D. R., Gallagher, D. A., Massey, L. A., Silveira‐Moriyama, L., & Lees, A. J. (2008) · Movement Disorders · doi:10.1002/mds.21813 · Cited by 290
Self-citationCerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View
Revesz, T., Ghiso, J., Lashley, T., Plant, G., Rostagno, A., Frangione, B., & Holton, J. L. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.9.885 · Cited by 288
Self-citationSchneider, S. A., Edwards, M. J., Mir, P., Cordivari, C., Hooker, J., Dickson, J., Quinn, N., & Bhatia, K. P. (2007) · Movement Disorders · doi:10.1002/mds.21685 · Cited by 247
Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18 F‐dopa PET study
Brooks, D. J., Playford, E. D., Ibanez, V., Sawle, G. V., Thompson, P. D., Findley, L. J., & Marsden, C. D. (1992) · Neurology · doi:10.1212/wnl.42.8.1554 · Cited by 232
Progression of Parkinsonian Signs in Parkinson Disease
Louis, E. D., Tang, M. X., Cote, L., Alfaro, B., Mejia, H., & Marder, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.334 · Cited by 211
Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases
Pletnikova, O., West, N., Lee, M. K., Rudow, G. L., Skolasky, R. L., Dawson, T. M., Marsh, L., & Troncoso, J. C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.10.006 · Cited by 209
Lewy body cortical involvement may not always predict dementia in Parkinson's disease
Colosimo, C. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.852 · Cited by 200
Patterns of levodopa response in Parkinson's disease: a clinico-pathological study
Kempster, P. A., Williams, D. R., Selikhova, M., Holton, J., Revesz, T., & Lees, A. J. (2007) · Brain · doi:10.1093/brain/awm142 · Cited by 191
Self-citationParkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis
Schiess, M. C., Zheng, H., Soukup, V. M., Bonnen, J. G., & Nauta, H. J. W. (2000) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(99)00051-6 · Cited by 175
Dementia with Lewy bodies and Parkinson's disease with dementia: Are they different?
Tsuboi, Y., & Dickson, D. W. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.10.014 · Cited by 172
Lashley, T., Holton, J. L., Gray, E., Kirkham, K., O’Sullivan, S. S., Hilbig, A., Wood, N. W., Lees, A. J., & Revesz, T. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0336-0 · Cited by 172
Self-citationStriatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease
Spiegel, J., Hellwig, D., Samnick, S., Jost, W., Möllers, M.-O., Fassbender, K., Kirsch, C.-M., & Dillmann, U. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-006-0518-2 · Cited by 169
Ten-year follow-up of three different initial treatments in de-novo PD
Lees, A. J., Katzenschlager, R., Head, J. A., & Ben‐Shlomo, Y. (2001) · Neurology · doi:10.1212/wnl.57.9.1687 · Cited by 143
Self-citationFrancis, P. T., & Perry, E. K. (2007) · Movement Disorders · doi:10.1002/mds.21683 · Cited by 141
Graham, J., & SAGAR, H. J. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1<10::aid-mds1005>3.0.co;2-4 · Cited by 140
Josephs, K. A., Matsumoto, J. Y., & Ahlskog, J. E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.354 · Cited by 129
Morphological and functional imaging studies on the diagnosis and progression of Parkinson’s disease
Brooks, D. J. (2000) · Journal of Neurology · doi:10.1007/pl00007755 · Cited by 125
Prognostic significance of the onset mode in parkinsonism
Rajput, A. H., Pahwa, R., Pahwa, P., & Rajput, A. H. (1993) · Neurology · doi:10.1212/wnl.43.4.829 · Cited by 95
Clinical heterogeneity in newly diagnosed Parkinson’s disease
Post, B., Speelman, J. D., de Haan, R. J., & on behalf of the CARPA-study group (2008) · Journal of Neurology · doi:10.1007/s00415-008-0782-1 · Cited by 94
How to diagnose multiple system atrophy
Quinn, N. P. (2005) · Movement Disorders · doi:10.1002/mds.20534 · Cited by 66
Lewy Bodies in Progressive Supranuclear Palsy Represent an Independent Disease Process
Uchikado, H., DelleDonne, A., Ahmed, Z., & Dickson, D. W. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000218449.17073.43 · Cited by 65
Tremor dominant parkinsonism: Clinical description and LRRK2 mutation screening
Clarimón, J., Pagonabarraga, J., Paisán‐Ruiz, C., Campolongo, A., Pascual‐Sedano, B., Martí-Massó, J. F., Singleton, A., & Kulisevsky, J. (2007) · Movement Disorders · doi:10.1002/mds.21771 · Cited by 43
Does motor subtype influence neurocognitive performance in Parkinson’s disease without dementia?
Lyros, E., Messinis, L., & Papathanasopoulos, P. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.02046.x · Cited by 32
Cited by
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Challenges in the diagnosis of Parkinson's disease
Tolosa, E., Garrido, A., Scholz, S. W., & Poewe, W. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00030-2 · Cited by 1,874
Pathology of Neurodegenerative Diseases
Dugger, B. N., & Dickson, D. W. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028035 · Cited by 1,665
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
Irwin, D. J., Lee, V. M.-Y., & Trojanowski, J. Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3549 · Cited by 869
Missing pieces in the Parkinson's disease puzzle
Obeso, J. A., Rodriguez-Oroz, M. C., Goetz, C. G., Marin, C., Kordower, J. H., Rodriguez, M., Hirsch, E. C., Farrer, M., Schapira, A. H. V., & Halliday, G. (2010) · Nature Medicine · doi:10.1038/nm.2165 · Cited by 734
Metadata
- Authors
- Selikhova, M., Williams, D. R., Kempster, P. A., Holton, J. L., Revesz, T., & Lees, A. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-09-16
- Volume
- 132
- Issue
- 11
- Pages
- 2947-2957
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2017032419
- Cited by
- 461
- References
- 42
- FWCI
- 15.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.